Security Snapshot

Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) Institutional Ownership

CUSIP: 38341P102

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

181

Shares (Excl. Options)

169,589,690

Price

$0.33

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-15,395,619
Value change
-$77,470,486
Number of holders
181
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
236,211,947
SEC-reported price per share
$0.34
Insider filing price
$0.34
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 38341P102.
  • 181 institutions reported positions in Q1 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 195 to 181 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $573,488,877 to $55,714,825.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 181 institutions filings for Q1 2026.

Open SEC evidence

Security key

38341P102

Latest holder period

Q1 2026

13F holders

181

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
GOSS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.5% +24% $46,705,201 +$9,084,437 15,065,708 +24% BlackRock, Inc. 31 Dec 2025
683 Capital Management, LLC 3.9% -27% $3,732,522 -$1,200,000 9,331,304 -24% 683 Capital Management, LLC 18 Mar 2026
Octagon Capital Advisors LP 3.8% -39% $3,590,422 -$2,466,148 8,976,054 -41% Octagon Capital Advisors LP 31 Mar 2026
Invus Global Management, LLC 2.8% $5,507,814 6,258,880 Invus Public Equities, L.P. 31 Dec 2024
Growth Equity Opportunities 18 VGE, LLC 1.7% $10,366,092 4,065,134 Growth Equity Opportunities 18 VGE, LLC 23 Feb 2026

As of 31 Mar 2026, 181 institutional investors reported holding 169,589,690 shares of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS). This represents 72% of the company’s total 236,211,947 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
59%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.1% 16,826,695 -1.3% 0% $5,527,571
Kalehua Capital Management LLC 4.3% 10,236,293 2.4% $3,362,622
AQR CAPITAL MANAGEMENT LLC 4.3% 10,126,897 +805% 0% $3,326,687
VANGUARD CAPITAL MANAGEMENT LLC 4% 9,394,593 0% 0% $3,090,821
ARCH Venture Management, LLC 3.4% 8,055,916 0% 0.39% $2,646,368
Octagon Capital Advisors LP 3.3% 7,750,000 -44% 0.28% $2,545,875
SAMSARA BIOCAPITAL, LLC 3.1% 7,222,559 0% 0.23% $2,372,611
Balyasny Asset Management L.P. 2.5% 5,922,298 +290% 0% $1,945,475
ACADIAN ASSET MANAGEMENT LLC 2.2% 5,277,904 +19% 0% $1,729,000
Siren, L.L.C. 2.2% 5,208,968 0% 0.05% $1,711,146
683 Capital Management, LLC 2.1% 5,000,000 -3.7% 0.15% $1,642,500
HHLR ADVISORS, LTD. 2.1% 4,974,041 0% 0.1% $1,633,972
GEODE CAPITAL MANAGEMENT, LLC 2.1% 4,939,691 +1.4% 0% $1,623,125
Qube Research & Technologies Ltd 2.1% 4,917,763 +810% 0% $1,615,485
TWO SIGMA INVESTMENTS, LP 2% 4,780,851 +41% 0% $1,570,510
STATE STREET CORP 1.9% 4,388,109 -53% 0% $1,441,494
Corient Private Wealth LLC 1.7% 3,985,383 +3.6% 0% $1,309,199
Squarepoint Ops LLC 1.4% 3,398,757 +1434% 0% $1,116,492
GSA CAPITAL PARTNERS LLP 1.4% 3,254,233 +6175% 0.07% $1,069,000
BANK OF AMERICA CORP /DE/ 1.3% 3,173,725 +66% 0% $1,040,982
BARCLAYS PLC 1.3% 3,065,806 +432% 0% $1,007,118
VANGUARD PORTFOLIO MANAGEMENT LLC 0.91% 2,161,079 0% 0% $710,995
Alyeska Investment Group, L.P. 0.87% 2,051,442 +126% 0% $673,899
UBS Group AG 0.8% 1,883,583 +6.3% 0% $619,699
Ensign Peak Advisors, Inc 0.72% 1,702,125 0% $559,148

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 169,589,690 $55,714,825 -$77,470,486 $0.33 181
2025 Q4 185,008,788 $573,488,877 +$17,712,101 $3.10 195
2025 Q3 180,099,232 $473,650,742 +$14,481,997 $2.63 162
2025 Q2 177,241,575 $218,003,209 +$9,779,866 $1.23 123
2025 Q1 169,972,743 $186,887,807 -$1,268,144 $1.10 118
2024 Q4 171,313,829 $154,975,691 -$4,643,111 $0.90 102
2024 Q3 174,874,615 $172,644,460 -$19,949,532 $0.99 99
2024 Q2 182,850,284 $164,736,451 -$20,026,799 $0.90 93
2024 Q1 197,765,806 $233,516,476 -$11,193,563 $1.18 105
2023 Q4 203,270,485 $185,471,165 +$4,883,709 $0.91 96
2023 Q3 205,596,440 $171,215,346 +$117,834,337 $0.83 93
2023 Q2 62,010,889 $74,414,154 -$19,164,753 $1.20 94
2023 Q1 77,679,537 $97,875,805 -$40,109,226 $1.26 107
2022 Q4 103,773,723 $225,185,263 -$165,052,760 $2.17 117
2022 Q3 85,232,624 $1,021,045,667 +$262,239,455 $11.98 154
2022 Q2 63,691,207 $533,207,849 +$32,485,845 $8.37 126
2022 Q1 59,875,031 $519,727,258 +$5,179,881 $8.68 138
2021 Q4 58,810,100 $664,847,746 +$43,218,257 $11.31 129
2021 Q3 54,748,025 $687,740,924 +$24,001,097 $12.57 123
2021 Q2 53,088,201 $431,075,177 -$10,198,257 $8.12 109
2021 Q1 54,256,286 $501,857,885 +$8,880,956 $9.25 121
2020 Q4 53,109,159 $513,580,534 -$47,148,476 $9.67 119
2020 Q3 55,543,085 $689,284,591 +$37,297,727 $12.41 122
2020 Q2 52,506,803 $683,821,623 +$177,437,307 $13.00 108
2020 Q1 39,039,096 $396,249,329 -$15,719,655 $10.15 95
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .